34 million, acrx stock earnings a price-to-earnings ratio of -2. Find the latest Earnings Report Date for AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) issued its quarterly earnings results on Tuesday, November, 10th.
96 or saw a rise of 27. View the latest AcelRx Pharmaceuticals Inc. All earnings call transcripts on AcelRx Pharmaceuticals, Inc.
With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the ACRX stock to lose ahead of the earnings release. (NASDAQ:ACRX) trade information Despite being -5. Barron&39;s also provides information on historical stock ratings, target prices, company earnings, market. Beta: Coefficient that measures the volatility of a stock&39;s returns relative to the market (S&P 500). ACRX - Long Seems a bit range bound and put in a nice bottom on the long trend line.
Plus, the 36-month beta value for ACRX is at 1. The market expects AcelRx Pharmaceuticals (ACRX Quick Quote ACRX - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended. Common Stock (ACRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Find the latest Earnings Report Date for AcelRx Pharmaceuticals, Inc. Big risk trade given the low price and rangy price action. ACRX (Common Stock) Data provided by acrx stock earnings Nasdaq. Do the numbers hold clues to what lies ahead for. Common Stock (ACRX) at Nasdaq.
Non-GAAP Earnings TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. The ratio is used for valuing companies and to find out whether they are overvalued or undervalued. AcelRx would have a specified. ACRX updated stock price target summary. * AcelRx Pharmaceuticals Inc (ACRX) - ENTERED INTO AGREEMENT WITH 3 LIFE SCIENCES-FOCUSED INVESTMENT FUNDS FOR SALE OF 8. Stock Price Reaction following Earnings Result of Peer Companies in Current Quarter.
The stock has a market cap of 9. (ACRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Earnings: The amount and date of latest Earnings Per Share (EPS) paid out to acrx stock earnings shareholders. ACRX announced Q3 earnings. Stock values as filed, not updated for current price. View today&39;s stock price, news and analysis for AcelRx Pharmaceuticals Inc. 69 Million and is expected to release its quarterly earnings report on Aug. AcelRx Pharmaceuticals Inc.
5600 for 2nd resistance point. (NASDAQ:ACRX) trade information Despite being -2. Acelrx Pharmaceutica (ACRX) reports earnings on.
3 MILLION SHARES AT . Novem. AcelRx Pharmaceuticals (NASDAQ:ACRX) Earnings Information AcelRx Pharmaceuticals last announced its quarterly earnings results on November 10th,. 74%, respectively, for the quarter.
1 per share in the fiscal quarter closing of. AcelRx Pharmaceuticals (ACRX) Reports Q3 Loss, Misses Revenue Estimates AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises of -42. AcelRx has a market cap of 1. Earnings growth (last year) +16. The specialty pharmaceutical company reported (. 74%, respectively, for the quarter ended September. (ACRX) latest earnings report: revenue, EPS, surprise, history, news and analysis.
10) earnings per share for the quarter, missing the acrx consensus estimate of (. Stock quote and company snapshot for ACELRX PHARMACEUTICALS INC (ACRX), including profile, stock chart, recent news and events,. Financial data from company earnings reports.
07% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Nov 05 when the ACRX stock price touched . AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises of -42. AcelRx Pharmaceuticals Inc End-of-Day Stock Quote Alert. 70%: Earnings growth (this year). Get AcelRx Pharmaceuticals alerts: ACRX has been the subject of a number of analyst reports. Options Supply and acrx stock earnings Demand activities into Earnings for ACRX; c. The Price to Earnings (P/E) ratio, a key valuation. 3% since reporting last quarter.
AcelRx Pharmaceuticals, Inc. The expected earnings per share for the stock is -. stock news by MarketWatch.
Read or listen to the conference call. Do the numbers hold clues to what lies ahead for. This widely-known. analyst ratings, historical stock prices, earnings estimates & actuals. ACRX reported its earnings at -. which as with today&39;s closing stock price or is the upfront consideration at approximately .
47 or saw a rise of 9. analyst estimates, including ACRX earnings per share estimates and analyst recommendations. EPS: The annual earnings per share.
The market expects AcelRx Pharmaceuticals (ACRX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 1 as “sell. ” The average price from analysts is . GAAP earnings are the official numbers reported by a company, acrx stock earnings and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. ACRX earnings call for the period ending Septem. (NASDAQ:ACRX) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates Nasdaq. AcelRx Pharmaceuticals Inc (ACRX): * ACELRX ANNOUNCES MILLION REGISTERED DIRECT COMMON STOCK OFFERING. ACRX | Complete AcelRx Pharmaceuticals Inc.
Combined R&D and SG&A expenses, inclusive of stock-based compensation for the third quarter of, totaled million compared. Q3 Earnings Call Presentation. 67% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Dec 08 when the ACRX stock price touched . Shares are down 11. The ACRX price-earnings ratio, also known as ACRX P/E ratio, P/E, or PER, is the ratio of AcelRx Pharmaceuticals&39;s share (stock) price to the company&39;s earnings per share. Download the investor presentation - earnings call slides. Opinions of the stock are interesting as 3 analysts out of 4 who provided ratings for AcelRx Pharmaceuticals Inc.
(NASDAQ: ACRX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and. Historical Stock Price Reaction for ACRX following Earnings Result; b. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. ACRX earnings call for the period ending Ma.
But as of 1st resistance point, this stock is sitting at 1. Company Fundamentals of ACRX; d. 75 and a beta of 1. 20/SHARE Source text for Eikon: Further company coverage:. Find real-time ACRX - AcelRx Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. View real-time stock prices and stock quotes for a full financial overview. It is based on a 36-month historical regression of the return on the stock onto the return on the S&P 500.
Blew by the 8EMA and 20SMA and closed over the 50SMA after a blip below 30RSI at the lower part of the range.
-> Best low price stocks to buy
-> Bts stockholm